Simulation of airflow and aerosol deposition in the nasal cavity of a 5-year-old child

Journal of Aerosol Science

Volumn 42, Issue 3, 2011, Pages 156-173

  Xi, Jinxiang ^a   Si, Xiuhua ^b   Kim, Jong Won ^a   Berlinski, Ariel ^c,d  

^a University of Arkansas   (United States)

^b CALVIN COLLEGE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

Breathing resistance; Child airway model; Child adult difference; Microdosimetry; Nasal deposition; Nasal physiology

Indexed keywords

AEROSOLS; DEPOSITION RATES; EFFICIENCY; MAGNETIC RESONANCE IMAGING; PASSIVE FILTERS; PHYSIOLOGY; RESPIRATORY MECHANICS; REYNOLDS NUMBER; RISK ASSESSMENT; TURBULENCE MODELS;

AIRWAY MODELING; CHILD-ADULT DIFFERENCE; EMPIRICAL CORRELATIONS; FILTERING EFFICIENCY; K-OMEGA TURBULENCE MODEL; MICRO-DOSIMETRY; PARTICLE DEPOSITIONS; PARTICLE TRAJECTORIES;

ATMOSPHERIC MOVEMENTS;

AIRFLOW; ATMOSPHERIC DEPOSITION; BODY MASS; CHILD HEALTH; EXPERIMENTAL STUDY; HEALTH RISK; LAGRANGIAN ANALYSIS; PHYSIOLOGICAL RESPONSE; RESPIRATION; RESPIRATORY DISEASE; REYNOLDS NUMBER; RISK ASSESSMENT; TURBULENT FLOW;

AEROSOL; AIRBORNE PARTICLE; AIRFLOW; AIRWAY; ARTICLE; CASE REPORT; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TRANSPORT; FILTRATION; HUMAN; INHALATION; LARYNX; MALE; MODEL; NOSE CAVITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SIMULATION; VALIDATION PROCESS;

EID: 78651540144     PISSN: 00218502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaerosci.2010.12.004     Document Type: Article

References (70)

1. Asgharian B., Menache M.G., Miller F.J. Modeling age-related particle deposition in humans. Journal of Aerosol Medicine 2004, 17(3):213-224.
2. Balashazy I., Hofmann W., Heistracher T. Computation of local enhancement factors for the quantification of particle deposition patterns in airway bifurcations. Journal of Aerosol Science 1999, 30:185-203.
3. Becquemin M., Swift D.L., Bouchikhi A., Roy M., Teillac A. Particle deposition and resistance in the noses of adults and children. European Respiratory Journal 1991, 4(6):694-702.
4. Bennett W.D., Zeman K.L., Jarabek A.M. Nasal contribution to breathing and fine particle deposition in children versus adults. Journal of Toxicology and Environmental Health, Part A: Current Issues 2008, 71(3):227-237.
5. Brancatisano T., Collett P.W., Engel L.A. Respiratory movements of the vocal cords. Journal of Applied Physiology 1983, 54(4):1269-1276.
6. Bridger G.P. Physiology of nasal valve. Archives of Otolaryngology 1970, 92(6):543-&.
7. Bridger G.P., Proctor D.F. Maximum nasal inspiratory flow and nasal resistance. Annals of Otology Rhinology and Laryngology 1970, 79(3):481-&.
8. Cheng Y.S. Aerosol deposition in the extrathoracic region. Aerosol Science and Technology 2003, 37:659-671.
9. Cheng K.H., Cheng Y.S., Yeh H.C., Guilmette R.A., Simpson S.Q., Yang S.Q., et al. In vivo measurements of nasal airway dimensions and ultrafine aerosol depositing in human nasal and oral airways. Journal of Aerosol Science 1996, 27:785-801.
10. Cheng Y.S., Smith S.M., Yeh H.C., Kim D.B., Cheng K.H., Swift D.L. Deposition of ultrafine aerosols and thoron progeny in replicas of nasal airways of young children. Aerosol Science and Technology 1995, 23:541-552.
11. Cheng Y.S., Su Y.F., Yeh H.C., Swift D.L. Deposition of Thoron progeny in human head airways. Aerosol Science and Technology 1993, 18:359-375.
12. Cheng Y.S., Yamada Y., Yeh H.C., Swift D.L. Diffusional deposition of ultrafine aerosols in a human nasal cast. Journal of Aerosol Science 1988, 19:741.
13. Cheng Y.S., Yeh H.C., Guilmette R.A., Simpson S.Q., Cheng K.H., Swift D.L. Nasal deposition of ultrafine particles in human volunteers and its relationship to airway geometry. Aerosol Science and Technology 1996, 25(3):274-291.
14. Crawford D.J. Identifying critical human subpopulations by age groups: Radioactivity and the lung. Physics in Medicine and Biology 1982, 27(4):539-552.
15. Diot P., Palmer Lucy B., Smaldone A., Decelie-Germana J., Grimson R., Smaldone Gerald C. RhDNase I aerosol deposition and related factors in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 1997, 156(5):1662-1668.
16. Eccles R. A role for the nasal cycle in respiratory defence. European Respiratory Journal 1996, 9(2):371-376.
17. Everard M.L. Inhalation therapy for infants. Advanced Drug Delivery Reviews 2003, 55(7):869-878.
18. Fodil R., Brugel-Ribere L., Croce C., Sbirlea-Apiou G., Larger C., Papon J.F., et al. Inspiratory flow in the nose: a model coupling flow and vasoerectile tissue distensibility. Journal of Applied Physiology 2005, 98(1):288-295.
19. Foos B., Marty M., Schwartz J., Bennett W., Moya J., Jarabek A.M., et al. Focusing on children's inhalation dosimetry and health effects for risk assessment: an introduction. Journal of Toxicology and Environmental Health, Part A: Current Issues 2008, 71(3):149-165.
20. Gill P.E., Murray W. Algorithms for the solution of the nonlinear least-squares problem. SIAM Journal on Numerical Analysis 1978, 15(5):977-992.
21. Gradon L., Yu C.P. Diffusional particle deposition in the human nose and mouth. Aerosol Science and Technology 1989, 11:213-220.
22. Guilmette R.A., Cheng Y.S., Yeh H.C., Swift D.L. Deposition of 0.005-12 micrometer monodisperse particles in a computer-milled, MRI-based nasal airway replica. Inhalation Toxicology 1994, 6(Suppl. 1):395-399.
23. Heyder J., Gebhart J., Rudolf G., Schiller C.F., Stahlhofen W. Deposition of particles in the human respiratory tract in the size range of 0.005-15 microns. Journal of Aerosol Science 1986, 17(5):811-825.
24. Hilberg O., Jensen F.T., Pedersen O.F. Nasal airway geometry: comparison between acoustic reflections and magnetic resonance scanning. Journal of Applied Physiology 1993, 75(6):2811-2819.
25. Hubal E.A.C., Kimbell J.S., Fedkiw P.S. Incorporation of nasal-lining mass-transfer resistance into a CFD model for prediction of ozone dosimetry in the upper respiratory tract. Inhalation Toxicology 1996, 8(9):831-857.
26. Janssens H.M., De Jongste J.C., Fokkens W.J., Robben S.G.F., Wouters K., Tiddens H. The Sophia Anatomical Infant Nose-Throat (SAINT) model: A valuable tool to study aerosol deposition in infants. Journal of Aerosol Medicine-Deposition Clearance and Effects in the Lung 2001, 14(4):433-441.
27. Kelly J.T., Asgharian B., Kimbell J.S., Wong B. Particle deposition in human nasal airway replicas manufactured by different methods. Part I: Inertial regime particles. Aerosol Science and Technology 2004, 38:1063-1071.
28. Kelly J.T., Asgharian B., Kimbell J.S., Wong B. Particle deposition in human nasal airway replicas manufactured by different methods. Part II: Ultrafine particles. Aerosol Science and Technology 2004, 38:1072-1079.
29. Keyhani K., Scherer P.W., Mozell M.M. Numerical simulation of airflow in the human nasal cavity. Journal of Biomechanical Engineering-Transactions of the ASME 1995, 117(4):429-441.
30. Kimbell J.S., Segal R.A., Asgharian B., Wong B.A., Schroeter J.D., Southall J.P., et al. Characterization of deposition from nasal spray devices using a computational fluid dynamics model of the human nasal passages. Journal of Aerosol Medicine-Deposition Clearance and Effects in the Lung 2007, 20(1):59-74.
31. Kleinstreuer C., Zhang Z., Donohue J.F. Targeted drug aerosol delivery in human respiratory system. Annual Review of Biomedical Engineering 2008, 10:195-220.
32. Lee Z., Berridge M.S. PET imaging-based evaluation of aerosol drugs and their delivery devices: nasal and pulmonary studies. IEEE Transactions on Medical Imaging 2002, 21:1324-1331.
33. Liu Y., Matida E.A., Gu J., Johnson M.R. Numerical simulation of aerosol deposition in a 3-D human nasal cavity using RANS, RANS/EIM, and LES. Aerosol Science 2007, 38:683-700.
34. Longest P.W., Xi J. Effectiveness of direct Lagrangian tracking models for simulating nanoparticle deposition in the upper airways. Aerosol Science and Technology 2007, 41:380-397.
35. Lumb A.B. Nunn's Applied Respiratory Physiology 2000, Butterworth Heinemann, Oxford.
36. Martonen T.B., Zhang Z.Q., Yue G., Musante C.J. Fine particle deposition within human nasal airways. Inhalation Toxicology 2003, 15(4):283-303.
37. Matida E.A., Finlay W.H., Grgic L.B. Improved numerical simulation of aerosol deposition in an idealized mouth-throat. Journal of Aerosol Science 2004, 35:1-19.
38. Mirza N., Kroger H., Doty R.L. Influence of age on the 'nasal cycle'. Laryngoscope 1997, 107(1):62-66.
39. Morsi S.A., Alexander A.J. An investigation of particle trajectories in two-phase flow systems. Journal of Fluid Mechanics 1972, 55(2):193-208.
40. Ohki M., Ogoshi T., Yuasa T., Kawano K., Kawano M. Extended observation of the nasal cycle using a portable rhinoflowmeter. Journal of Otolaryngology 2005, 34(5):346-349.
41. Oldham M.J., Mannix R.C., Phalen R.F. Deposition of monodisperse particles in hollow models representing adult and child-size tracheobroncial airways. Health Physics 1997, 72(6):827-833.
42. Phalen R.F., Cuddihy R.G., Fisher R.G., Moss O.R., Schlesinger R.B., Swift D.L., et al. Main features of the proposed NCRP respiratory tract dosimetry model. Radiation Protection Dosimetry. 1991, 38:179-184.
43. Phalen R.F., Oldham M.J., Beaucage C.B., Crocker T.T., Mortensen J.D. Postnatal enlargement of human tracheobronchial airways and implications for particle deposition. Anatomical Record 1985, 212:368-380.
44. Phalen R.F., Oldham M.J., Mautz W.J. Aerosol deposition in the nose as a function of body size. Health Physics 1989, 57, Suppl.(1):299-305.
45. Pickering D.N., Beardsmore C.S. Nasal flow limitation in children. Pediatric Pulmonology 1999, 27(1):32-36.
46. Rasmussen T.R., Andersen A., Pedersen O.F. Particle deposition in the nose related to nasal cavity geometry. Rhinology 2000, 38:102-107.
47. Scherer P.W., Keyhani K., Mozell M.M. Nasal dosimetry modeling for humans. Inhalation Toxicology 1994, 6:85-97.
48. Schroeter J.D., Musante C.J., Hwang D.M., Burton R., Guilmette R., Martonen T.B. Hygroscopic growth and deposition of inhaled secondary cigarette smoke in human nasal pathways. Aerosol Science and Technology 2001, 34(1):137-143.
49. Segal R.A., Kepler G.M., Kimbell J.S. Effects of differences in nasal anatomy on airflow distribution: A comparison of four individuals at rest. Annals of Biomedical Engineering 2008, 36(11):1870-1882.
50. Shi H., Kleinstreuer C., Zhang Z. Laminar airflow and nanoparticle or vapor deposition in a human nasal cavity model. Journal of Biomechanical Engineering 2006, 128:697-706.
51. Stahlhofen W., Rudolf G., James A.C. Intercomparison of experimental regional aerosol deposition data. Journal of Aerosol Medicine 1989, 2(3):285-308.
52. Storey-Bishoff J., Noga M., Finlay W.H. Deposition of micrometer-sized aerosol particles in infant nasal airway replicas. Journal of Aerosol Science 2008, 39(12):1055-1065.
53. Subramaniam R.P., Richardson R.B., Morgan K.T., Kimbell J.S., Guilmette R.A. Computational fluid dynamics simulations of inspiratory airflow in the human nose and nasopharynx. Inhalation Toxicology 1998, 10(2):91-120.
54. Suman J.D., Laube B.L., Dalby R. Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition, absorption, and biologic response. Journal of Aerosol Medicine 2006, 19(4):510-521.
55. Swift D.L. Inspiratory inertial deposition of aerosols in human airway replicate casts: Implication for the proposed NCRP Lung Model. Radiation Protection Dosimetry 1991, 38:29-34.
56. Swift D.L., Strong J.C. Nasal deposition of ultrafine 218Po aerosols in human subjects. Journal of Aerosol Science 1996, 27(7):1125-1132.
57. Tian L., Ahmadi G. Particle deposition in turbulent duct flows-Comparisons of different model predictions. Journal of Aerosol Science 2007, 38:377-397.
58. U.S.General Surgeon Report The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General-Executive Summary 2006, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordination Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
59. US_FDA Draft Guidance for Industry: Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action 2003, US Food and Drug Administration, Washington, DC.
60. Wheatley J.R., Amis T.C., Engel L.A. Nasal and oral airway pressure-flow relationships. Journal of Applied Physiology 1991, 71(6):2317-2324.
61. Wilcox D.C. Turbulence Modeling for CFD 1998, DCW Industries, Inc., California. 2nd ed.
62. Xi J., Longest P.W. Transport and deposition of micro-aerosols in realistic and simplified models of the oral airway. Annals of Biomedical Engineering 2007, 35(4):560-581.
63. Xi J., Longest P.W. Numerical predictions of submicrometer aerosol deposition in the nasal cavity using a novel drift flux approach. International Journal of Heat and Mass Transfer 2008, 51(23-24):5562-5577.
64. Xi J., Longest P.W. Characterization of submicrometer aerosol deposition in extrathoracic airways during nasal exhalation. Aerosol Science and Technology 2009, 43(8):808-827.
65. Xi J., Longest P.W., Martonen T.B. Effects of the laryngeal jet on nano- and microparticle transport and deposition in an approximate model of the upper tracheobronchial airways. Journal of Applied Physiology 2008, 104(6):1761-1777.
66. Xu G.B., Yu C.P. Effects of age on deposition of inhaled aerosols in the human lung. Aerosol Science and Technology 1986, 5(3):349-357.
67. Yamada Y., Cheng Y.S., Yeh H.C., Swift D.L. Inspiratory and expiratory deposition of ultrafine particles in a human nasal cast. Inhalation Toxicology 1988, 1:1-11.
68. Yu G., Zhang Z., Lessmann R. Fluid flow and particle diffusion in the human upper respiratory system. Aerosol Science and Technology 1998, 28:146.
69. Zamankhan P., Ahmadi G., Wang Z., Hopke P.K., Cheng Y.S., Su W.C., et al. Airflow and deposition of nano-particles in a human nasal cavity. Aerosol Science and Technology 2006, 40:463-476.
70. Zhao K., Scherer P.W., Hajiloo S.A., Dalton P. Effects of anatomy on human nasal air flow and odorant transport patterns: Implications for olfaction. Chemical Senses 2004, 29(5):365-379.